The board of the California Institute for Regenerative Medicine meets in Berkeley Wednesday. It's expected to vote to spend as much as $40 million on genomic research, the study of genes and their relationships. Scientists from across California and beyond have been vying for this major investment -- but a consortium from Stanford is considered the favorite. We talk with David Jensen, who writes the California Stem Cell Report.
upper waypoint
lower waypoint
next waypoint
To learn more about how we use your information, please read our privacy policy.